Saturday, November 19, 2022 9:15:29 PM
Iron Mike,
You're right, just a few wealthier Americans' might go to the U.K. or perhaps Canada if they follow the British lead. Lots of Americans' will however be pressuring the FDA to act. I don't want to see shareholder as active as they were with DNDN, going to Congress, actively protesting for the approval of Provenge. I really don't believe it helped, though eventually Provenge was approved. I wish I could be certain that all the activism by shareholders didn't actually delay the FDA approval.
I actually believe the FDA is very satisfied with how NWBO has conducted themselves. I suspect the biggest issue with the FDA is the acceptance of the FlaskWorks units for commercial production, once we're over that hump I believe it will just be a matter of time until a facility is ready to be inspected for commercial production, then everything else will fall into place.
When IMGN filed their BLA and got their PDUFA date I publicly indicated that I believed the FDA could announce up to a month before the date, they did announce approval 2 weeks before the date. I believe that essentially the same thing will be true of NWBO, once a PDUFA date is established, approval is possible at any time in the last 4 or even perhaps 6 weeks before it.
Don't bet the FDA won't step up shortly after the U.K., but I'd be very surprised if they beat them to the punch.
Gary
You're right, just a few wealthier Americans' might go to the U.K. or perhaps Canada if they follow the British lead. Lots of Americans' will however be pressuring the FDA to act. I don't want to see shareholder as active as they were with DNDN, going to Congress, actively protesting for the approval of Provenge. I really don't believe it helped, though eventually Provenge was approved. I wish I could be certain that all the activism by shareholders didn't actually delay the FDA approval.
I actually believe the FDA is very satisfied with how NWBO has conducted themselves. I suspect the biggest issue with the FDA is the acceptance of the FlaskWorks units for commercial production, once we're over that hump I believe it will just be a matter of time until a facility is ready to be inspected for commercial production, then everything else will fall into place.
When IMGN filed their BLA and got their PDUFA date I publicly indicated that I believed the FDA could announce up to a month before the date, they did announce approval 2 weeks before the date. I believe that essentially the same thing will be true of NWBO, once a PDUFA date is established, approval is possible at any time in the last 4 or even perhaps 6 weeks before it.
Don't bet the FDA won't step up shortly after the U.K., but I'd be very surprised if they beat them to the punch.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
